Home › Geographic Atrophy › Florida
Geographic Atrophy clinical trials in Florida
8 studies for Geographic Atrophy are looking for participants at sites in Florida.
Cities in Florida
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Vitreo Retinal Associates - Gainesville- Site Number : 8400004, Gainesville
- Retina Vitreous Associates of Florida - St. Petersburg- Site Number : 8400002, St. Petersburg
RecruitingPhase 1/2
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Advanced Retina Institute-Ophthalmology, Bonita Springs
- Advanced Research, Coral Springs
- Retina Group of Florida, Fort Lauderdale
- and 11 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Retina Vitreous Associates of Florida, St. Petersburg
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 15, 2026 · NCT05626114A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Group of Florida, Fort Lauderdale
- VitreoRetinal Associates, PA, Gainesville
- Retina Specialty Institute, Pensacola
- and 1 more
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- Retina Group of Florida, Sarasota
- and 1 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Retina Specialty Institute, Pensacola
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT03011541Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Sarasota Retina Institute, Sarasota
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.